Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12229
Abstract: We conducted a historical cohort study of patients with schizophrenia to identify more robust risk factors at discharge that contribute to readmission within a year. read more here.
Keywords: treated combined; readmission schizophrenia; risk factors; risk ... See more keywords
Effect of apple vinegar intake on metabolic parameters and constipation in patients with schizophrenia treated with clozapine: a pilot study
Sign Up to like & getrecommendations! Published in 2020 at "Nordic Journal of Psychiatry"
DOI: 10.1080/08039488.2020.1799432
Abstract: Abstract Purpose Clozapine is one of the drugs that cause the highest level of weight gain. Additionally, obese patients are at higher risk of developing various physical co-morbidities, such as type 2 diabetes and cardiovascular… read more here.
Keywords: apple vinegar; patients schizophrenia; study; pilot ... See more keywords
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
Sign Up to like & getrecommendations! Published in 2023 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s394220
Abstract: Purpose The COVID-19 pandemic substantially impacted care of patients with schizophrenia treated with long-acting injectable antipsychotics (LAIs). This study (OASIS-MAPS) examined how clinical sites adapted operations and used telepsychiatry to maintain standard of care for… read more here.
Keywords: schizophrenia treated; treated long; patients schizophrenia; covid pandemic ... See more keywords